Nermin KÖŞÜŞ, Aydın KÖŞÜŞ, Nilgün TURHAN

Mean platelet volume as a marker of future cardiovascular disease risk in pregnant women with impaired fasting glucose and impaired glucose tolerance

To compare the mean platelet volume (MPV) of pregnant women with mild glycemic disorders with that of healthy pregnant women to find whether these disorders are risk factors for future cardiovascular disease. Materials and methods: Fasting blood glucose and 50-g oral glucose loading were measured. A 100-g, 3-h oral glucose tolerance test was done when plasma glucose was ≥140 mg/dL, following a loading test. According to the test results, 4 groups were formed: control, impaired fasting glucose, false positive loading test, and impaired glucose tolerance. The hematologic parameters were compared in all of the groups. Results: The mean MPV of the control group was lower than those of the other groups. The MPV had high sensitivity in prediction of the false positive loading test (sensitivity: 70.0%, specificity: 55.2%, AUC = 0.602, P = 0.029) and impaired glucose tolerance (sensitivity: 73.1%, specificity: 46.1%, AUC = 0.621, P = 0.009), although its sensitivity was lower than the others in prediction of impaired fasting glucose (sensitivity: 60.7%, specificity: 58.2%, AUC = 0.558, P = 0.374). Conclusion: Mild glycemic disorders are associated with increased MPV. Increased MPV might be associated with elevated baseline cardiovascular risk factors. Individuals with these glycemic disorders might be more aggressively targeted with strategies to lower cardiovascular disease risk.

Anahtar Kelimeler:

Key words: Impaired glucose tolerance, impaired fasting glucose, mean platelet volume, cardiovascular disease risk, pregnancy

Mean platelet volume as a marker of future cardiovascular disease risk in pregnant women with impaired fasting glucose and impaired glucose tolerance

Keywords:

Key words: Impaired glucose tolerance, impaired fasting glucose, mean platelet volume, cardiovascular disease risk, pregnancy,

PDF

___

Bock G, Dalla Man C, Campioni M, Chittilapilly E, Basu R, Toff olo G et al. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 2006; 55: 3536-49.
Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors. Results from the Baltimore Longitudinal Study of Aging. Diabetes 2004; 53: 2095-100.
Andersson DKG, Svardsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995; 18: 1534-43. 4. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study Group): eff ects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65.
Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyorala K et al. Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor: the DECODE Study. Diabetologia 2004; 47: 2118-28.
Meigs JB, Nathan DM, D’Agostino RB Sr, William PW. Fasting and post-challenge glycemia and cardiovascular disease risk: the Framingham Off spring Study. Diabetes Care 2002; 25: 1845-50.
Tavil Y, Sen N, Yazıcı HU, Hızal F, Abacı A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Th romb Res 2007; 120: 245-50. 8. Kiliçli-Camur N, Demirtunç R, Konuralp C, Eskiser A, Başaran Y. Could mean platelet volume be a predictive marker for acute myocardial infarction? Med Sci Monit 2005; 11: 387-92.
McCabe DJ, Harrison P, Sidhu PS, Brown MM, Machin SJ. Circulating reticulated platelets in the early and late phases aft er ischaemic stroke and transient ischaemic attack. Br J Haematol 2004; 126: 861-9.
Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Q J Med 1993; 86: 739-42.
Khuwaja AK, Rafi que G, White F, Azam SI. Macrovascular complications and their associated factors among persons with type 2 diabetes in Karachi, Pakistan--a multi-center study. J Pak Med Assoc 2004; 54: 60-6.
American Diabetes Association. Gestational diabetes mellitus (position statement). Diabetes Care 2004; 27: 88-90.
Qiao Q, Pyorala K, Pyorala M, Nissinen A, Lindstrom J, Tilvis R et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J 2002; 23: 1267-75.
Saigo K, Yasunaga M, Ryo R. Mean platelet volume in diabetics. Rinsha Byar 1992; 40: 215-7.
Zuberi BF, Akhtar N, Afsar S. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and nondiabetic subjects. Singapore Med J 2008; 49: 114-6.
Coban E, Bostan F, Ozdogan M . Th e mean platelet volume in subjects with impaired fasting glucose. Platelets 2006; 17: 67-9.
Coban E, Kucuktag S, Basyigit S. Platelet activation in subjects with impaired glucose tolerance. Platelets 2007; 18: 591-4.